• About Us
  • Our Editorial Policy
  • Business Directory
  • Advertise with Us
  • Our Advertisers
  • Contact Us
Australia India News
  • Alluring India - Brisbane Banner
India News Australia
  • Home
  • Current Issue
    Past Issue
  • India News
  • Politics
  • Business
  • World
    World This Week
  • Community News
  • What's On
  • Others
    Yoga in Australia News COVID-19 Community News Naari IPL News Health Travel Entertainment
  • Migrants Expo
  • National Events
  • Please wait..
Business and Trade news

Sensex, Nifty trade lower in early deals, IT and pharma stocks under pressure

  • BY India News Newsdesk
  • April 24, 2026
  • 0 COMMENTS

Mumbai, April 24 (IANS) The domestic equity markets saw negative performance in early hours on Friday amid elevated geopolitical tensions and the Q4 earnings season.

Sensex was trading at 77,263, down 0.51 per cent or 400 points, while Nifty was down 0.41 per cent, or 100 points, in early trade amid panic selling in IT, financial and pharma stocks. However, support was seen in FMCG and chemical scrips.

Cipla, Infosys, Dr Reddy’s Laboratories, Sun Pharma, TCS and ICICI Bank were among the top laggards.

On the sectoral front, several indices in the red zone, with the Nifty IT index falling 1.57 per cent. The Nifty Private Bank index declined 0.31 per cent, while the Nifty Pharma index was down 0.27 per cent.

Analysts said that given the prevailing global uncertainties and elevated volatility, a cautious and selective investment strategy is recommended.

They advised investors to accumulate fundamentally strong stocks during market corrections.

“Fresh long positions should ideally be initiated only after the Nifty decisively breaks above and sustains the 24,500 level, which would signal improving sentiment and the possibility of a more sustained bullish trend,” analysts noted.

Market sentiment remains fragile and highly news-driven, with near-term direction likely to be influenced by geopolitical developments and movements in crude oil prices, they added.

Brent crude jumped nearly 2 per cent to $107 per barrel, while US West Texas Intermediate (WTI) rose around 2 per cent to $97.6 from the previous close.

In Asian markets, the Nikkei was trading 0.43 per cent higher at 59,394, the Hang Seng declined 0.37 per cent to 25,819, and the KOSPI was down 0.40 per cent to 6,450.15.

On the institutional front, foreign institutional investors (FIIs) extended their selling streak for the fourth consecutive session on Thursday and offloaded equities worth Rs 3,254 crore. On the other hand, domestic institutional investors (DIIs) purchased equities worth Rs 941 crore.

–IANS

ag/na

Post navigation

PM Modi shares glimpses of Hooghly boat ride; expresses gratitude to Maa Ganga
Hyundai Mobis Q1 net profit falls 14 pc on weaker vehicle demand

Related Post

Neelkanth Mishra to represent India at World Bank amid changing global order
June 5, 2026
Indian markets trade higher ahead of RBI policy decision
June 5, 2026
India, US make progress on bilateral trade agreement talks during USTR delegation visit
June 5, 2026
Rooftop solar units to cover 75 lakh households by Dec 2026: Union minister Pralhad Joshi
June 5, 2026

Our Current Issue

Alluring India 2026

Alluring India 2026

Our Advertisers

  • Battery Rebate australia
  • Bess Australia Solar Panels
  • Alluring India - Brisbane 2026

Follow Us

  • facebook
  • facebook
  • facebook
  • facebook
INDIA NEWS on YouTube in Australia, bring to our readers and subscribers national and international news, editorials, expert columns, community activities and interviews of political leaders, celebrities, business professionals, academics and sport personalities among others.
  • facebook
  • facebook
  • facebook
  • facebook

Category

  • Accident
  • Adani Australia
  • Advertorial
  • Arts & Culture
  • Ashes 2022
  • Australia

Recent News

  • Neelkanth Mishra to represent India at World...
  • PM Modi likely to visit Bengal for...

Subscribe Newsletter

Get the latest creative news from india news

  • Privacy Policy
  • Disclaimer